Submitted by Guilherme Lemeszenski (guilherme@nead.unesp.br) on 2013-08-22T18:54:09Z No. of bitstreams: 1 S0101-60832010000600001.pdf: 260210 bytes, checksum: 2cedf1aa397e6e6bb51947c64786d8fe (MD5); Made available in DSpace on 2013-08-22T18:54:09Z (GMT). No. of bitstreams: 1 S0101-60832010000600001.pdf: 260210 bytes, checksum: 2cedf1aa397e6e6bb51947c64786d8fe (MD5) Previous issue date: 2010-01-01; Made availabl...
Submitted by Vitor Silverio Rodrigues (vitorsrodrigues@reitoria.unesp.br) on 2014-05-27T11:25:56Z No. of bitstreams: 0Bitstream added on 2014-05-27T14:41:50Z : No. of bitstreams: 1 2-s2.0-79960075756.pdf: 1020940 bytes, checksum: 1f3d450a1c80839e119b162ee7e3b3ab (MD5); Made available in DSpace on 2014-05-27T11:25:56Z (GMT). No. of bitstreams: 0 Previous issue date: 2011-07-13; Instituto de Psiquiatria do Hospit...
BACKGROUND: The objective of this study is to evaluate the efficacy of milnacipran in outpatients experiencing severe MDD non-respondent to adequate time and dosing of SSRI therapy. METHODS: A 12 week multi-centric study open study was designed to evaluate the efficacy of milnacipran after a SRRI trial failure. Complete remission (HAMD-17 < 8) was the principal outcome. Secondary outcomes were response (HAM >...
CONTEXT: Among neuropsychiatric disorders caused by cerebrovascular factors, vascular depression is diagnosed in a small degree by general practitioners, causing morbid-mortality increase in elderly. CASE REPORT: That is a case of a 67 year-old-man with partial response after treatment with a Selective Serotonin Receptors Inhibitor, and severe autonomic adverse effects with other antidepressants. The addition o...